Adjuvant Therapy (as defined by the NCI): Treatment given after the primary treatment to increase the chances of a cure. Adjuvant therapy may include chemotherapy, radiation therapy, hormone therapy, or biological therapy.

Find out if you may be eligible to participate.

We are now enrolling patients in a Phase III clinical trial testing erlotinib as an adjuvant therapy in patients who have undergone surgery for non-small cell lung cancer with EGFR-positive tumors.

(Investigational use of the approved product, Tarceva® (erlotinib))

Should I volunteer to participate in a clinical trial?

Participating in clincial trials may provide you with an opportunity to try an investigational treatment for your specific condition and to help you become an active participant in your health care while contributing to medical research.